113 related articles for article (PubMed ID: 35582896)
1. F-Box Protein 11 Suppresses Cell Proliferation and Aerobic Glycolysis in Glioblastomas by Mediating the Ubiquitin Degradation of Cdc25A.
Liu C; Chen X; Zhang L; Liu J; Li C; Zhao J; Pu J; Tang P; Liu B; Huang X
J Neuropathol Exp Neurol; 2022 Jun; 81(7):511-521. PubMed ID: 35582896
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis.
Yang CH; Pfeffer SR; Sims M; Yue J; Wang Y; Linga VG; Paulus E; Davidoff AM; Pfeffer LM
J Biol Chem; 2015 Mar; 290(10):6037-46. PubMed ID: 25589783
[TBL] [Abstract][Full Text] [Related]
3. The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail.
Shao L; Zhang X; Yao Q
FEBS Open Bio; 2020 Sep; 10(9):1810-1820. PubMed ID: 32657545
[TBL] [Abstract][Full Text] [Related]
4. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.
Duan S; Cermak L; Pagan JK; Rossi M; Martinengo C; di Celle PF; Chapuy B; Shipp M; Chiarle R; Pagano M
Nature; 2012 Jan; 481(7379):90-3. PubMed ID: 22113614
[TBL] [Abstract][Full Text] [Related]
5. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
[TBL] [Abstract][Full Text] [Related]
6. PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis.
Liang J; Cao R; Zhang Y; Xia Y; Zheng Y; Li X; Wang L; Yang W; Lu Z
Nat Commun; 2016 Aug; 7():12431. PubMed ID: 27485204
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-targeted microbubble destruction-mediated silencing of FBXO11 suppresses development of pancreatic cancer.
Xue J; Chen S; Ge D; Yuan X
Hum Cell; 2022 Jul; 35(4):1174-1191. PubMed ID: 35437704
[TBL] [Abstract][Full Text] [Related]
8. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
Qin Y; Hu Q; Xu J; Ji S; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Zhang B; Yu X; Xu X
Cell Commun Signal; 2019 Mar; 17(1):30. PubMed ID: 30922330
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-Specific Protease 29 Regulates Cdc25A-Mediated Tumorigenesis.
Chandrasekaran AP; Woo SH; Sarodaya N; Rhie BH; Tyagi A; Das S; Suresh B; Ko NR; Oh SJ; Kim KS; Ramakrishna S
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071237
[TBL] [Abstract][Full Text] [Related]
10. FBXO11 promotes ubiquitination of the Snail family of transcription factors in cancer progression and epidermal development.
Jin Y; Shenoy AK; Doernberg S; Chen H; Luo H; Shen H; Lin T; Tarrash M; Cai Q; Hu X; Fiske R; Chen T; Wu L; Mohammed KA; Rottiers V; Lee SS; Lu J
Cancer Lett; 2015 Jun; 362(1):70-82. PubMed ID: 25827072
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H
Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the CRL4(Cdt2) ubiquitin ligase and cell-cycle exit by the SCF(Fbxo11) ubiquitin ligase.
Rossi M; Duan S; Jeong YT; Horn M; Saraf A; Florens L; Washburn MP; Antebi A; Pagano M
Mol Cell; 2013 Mar; 49(6):1159-66. PubMed ID: 23478441
[TBL] [Abstract][Full Text] [Related]
13. FBXO11 represses cellular response to hypoxia by destabilizing hypoxia-inducible factor-1α mRNA.
Ju UI; Park JW; Park HS; Kim SJ; Chun YS
Biochem Biophys Res Commun; 2015 Sep; 464(4):1008-1015. PubMed ID: 26187670
[TBL] [Abstract][Full Text] [Related]
14. Regulation of TGF-β signaling, exit from the cell cycle, and cellular migration through cullin cross-regulation: SCF-FBXO11 turns off CRL4-Cdt2.
Abbas T; Keaton M; Dutta A
Cell Cycle; 2013 Jul; 12(14):2175-82. PubMed ID: 23892434
[TBL] [Abstract][Full Text] [Related]
15. Rock2 regulates Cdc25A through ubiquitin proteasome system in hepatocellular carcinoma cells.
Liu T; Yu X; Li G; Yuan R; Wang Q; Tang P; Wu L; Liu X; Peng X; Shao J
Exp Cell Res; 2012 Oct; 318(16):1994-2003. PubMed ID: 22705122
[TBL] [Abstract][Full Text] [Related]
16. miR-376a inhibits the proliferation and invasion of osteosarcoma by targeting FBXO11.
Xu Q; Cheng L; Chen J; Lu W; Wang P
Hum Cell; 2019 Jul; 32(3):390-396. PubMed ID: 31079326
[TBL] [Abstract][Full Text] [Related]
17. Cdc25A inhibits autophagy-mediated ferroptosis by upregulating ErbB2 through PKM2 dephosphorylation in cervical cancer cells.
Wang C; Zeng J; Li LJ; Xue M; He SL
Cell Death Dis; 2021 Nov; 12(11):1055. PubMed ID: 34743185
[TBL] [Abstract][Full Text] [Related]
18. CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration.
Abbas T; Mueller AC; Shibata E; Keaton M; Rossi M; Dutta A
Mol Cell; 2013 Mar; 49(6):1147-58. PubMed ID: 23478445
[TBL] [Abstract][Full Text] [Related]
19. FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity.
Abida WM; Nikolaev A; Zhao W; Zhang W; Gu W
J Biol Chem; 2007 Jan; 282(3):1797-804. PubMed ID: 17098746
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.
Xue J; Chi Y; Chen Y; Huang S; Ye X; Niu J; Wang W; Pfeffer LM; Shao ZM; Wu ZH; Wu J
Oncogene; 2016 Jan; 35(4):448-58. PubMed ID: 25867061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
